JPH06507899A - 化合物 - Google Patents

化合物

Info

Publication number
JPH06507899A
JPH06507899A JP5500202A JP50020292A JPH06507899A JP H06507899 A JPH06507899 A JP H06507899A JP 5500202 A JP5500202 A JP 5500202A JP 50020292 A JP50020292 A JP 50020292A JP H06507899 A JPH06507899 A JP H06507899A
Authority
JP
Japan
Prior art keywords
alkyl
methyl
acid
thienyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5500202A
Other languages
English (en)
Japanese (ja)
Inventor
ジラルド，ジェラルド・ロバート
ヒル，デイビッド・テイラー
ウェインストック，ジョゼフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JPH06507899A publication Critical patent/JPH06507899A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP5500202A 1991-05-15 1992-05-14 化合物 Pending JPH06507899A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9110532,0 1991-05-15
GB919110532A GB9110532D0 (en) 1991-05-15 1991-05-15 Chemical compounds
PCT/US1992/004071 WO1992020651A2 (en) 1991-05-15 1992-05-14 N-(heteroaryl)-imidazolyl-alkenoic acids

Publications (1)

Publication Number Publication Date
JPH06507899A true JPH06507899A (ja) 1994-09-08

Family

ID=10695047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5500202A Pending JPH06507899A (ja) 1991-05-15 1992-05-14 化合物

Country Status (11)

Country Link
EP (1) EP0585383A4 (cg-RX-API-DMAC7.html)
JP (1) JPH06507899A (cg-RX-API-DMAC7.html)
AU (1) AU2156192A (cg-RX-API-DMAC7.html)
GB (1) GB9110532D0 (cg-RX-API-DMAC7.html)
IE (1) IE921539A1 (cg-RX-API-DMAC7.html)
MX (1) MX9202262A (cg-RX-API-DMAC7.html)
NZ (1) NZ242734A (cg-RX-API-DMAC7.html)
PT (1) PT100491A (cg-RX-API-DMAC7.html)
TW (1) TW211010B (cg-RX-API-DMAC7.html)
WO (1) WO1992020651A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA923496B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011500783A (ja) * 2007-10-22 2011-01-06 オーキッド リサーチ ラボラトリーズ リミテッド ヒストンデアセチラーゼ阻害剤

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
KR100587187B1 (ko) * 1997-10-29 2006-10-24 론자 아게 포르밀이미다졸의제조방법
KR100567183B1 (ko) * 1997-11-14 2006-06-13 론자 아게 포르밀이미다졸의제조방법
CA2274994A1 (en) * 1998-06-18 1999-12-18 Lonza Ag Process for the preparation of formylimidazoles
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG52330A1 (en) * 1989-06-14 1998-09-28 Smithkline Beecham Corp Imidazolyl-alkenoic acids
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011500783A (ja) * 2007-10-22 2011-01-06 オーキッド リサーチ ラボラトリーズ リミテッド ヒストンデアセチラーゼ阻害剤

Also Published As

Publication number Publication date
WO1992020651A2 (en) 1992-11-26
PT100491A (pt) 1993-09-30
EP0585383A4 (en) 1994-08-17
MX9202262A (es) 1992-11-01
AU2156192A (en) 1992-12-30
TW211010B (cg-RX-API-DMAC7.html) 1993-08-11
WO1992020651A3 (en) 1993-02-18
EP0585383A1 (en) 1994-03-09
NZ242734A (en) 1995-04-27
GB9110532D0 (en) 1991-07-03
IE921539A1 (en) 1992-11-18
ZA923496B (en) 1993-04-28

Similar Documents

Publication Publication Date Title
KR0165837B1 (ko) 이미다졸릴-알켄산 및 이의 제조방법 및 약제학적 조성물
EP0425211B1 (en) Substituted 5-((tetrazolyl)alkenyl)-imidazoles
JP2958055B2 (ja) イミダゾリルアルケン酸
AP525A (en) Imidazol-alkenoic acid and pharmaceutical compositions containing them.
JP2004520292A (ja) グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体
DE69133019T2 (de) Imidazolyl-alkencarbonsäuren
EP0585383A1 (en) Chemical compounds
US5177096A (en) Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical methods of use thereof
US5447949A (en) N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
HK1012384B (en) Imidazolyl-alkenoic acids
SI9200228A (sl) Imidazolil-alkenojske kisline
HK1012246B (en) Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists
HK1025315B (en) Imidazolyl-alkenoic acid